Scotland is home to a flourishing life science industry with government supported plans to increase its size to £8bn by 2025.
In May, Synpromics attended the ASGCT annual general meeting in Chicago.
Making the step from academia into industry can seem daunting and can appear to require a very different skill set.
In April, Synpromics attended the 6th annual Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day in New York, a full-day conference featuring discussi
As product developers move toward 2nd generation gene and cell medicine constructs, the importance of novel gene regulation and promoter elements has emerged.